medical marijuana

A cannabis product called delta-8 was made legal when the 2018 Farm Bill legalized hemp. But unlike its cousin CBD, delta-8 has psychoactive properties. And the FDA warns it has “serious health risks.” The agency has received more than 100 reports of bad reactions among people who consumed it.

The health department issues a “written notice of intent” for Terry Donnell Gwinn of Suwannee County, setting the stage for what could be protracted litigation over the sought-after opportunity to join the medical pot industry.

The judge called out the DeSantis administration's foot-dragging as he issued a concurring opinion in an appeal by Louis Del Favero Orchids, which has long sought a license for a treatment center.

The dosing and supply caps came nearly six years after voters approved a constitutional amendment broadly legalizing medical marijuana and more than three years after the Legislature authorized smokable marijuana.

With nearly 800,000 approved medical marijuana patients among a population of more than 22 million residents, investors are eagerly awaiting the chance to plant stakes in the state.

Agriculture Commissioner Nikki Fried has long championed medical marijuana, now legal in Florida. Her office also issues concealed weapons licenses. Her lawsuit cites a federal form that must be completed by people seeking to purchase guns.

The FDA has approved a cannabis-derived drug to treat some forms of epilepsy. Now people who have other forms of the condition are using over-the-counter products, but doctors and patients worry about the unbridled world of CBD, in which product ingredients can be a mystery.

Online companies are connecting patients and doctors, and sharing fees with the physicians, which could run afoul of a law prohibiting patient brokering. The activities are drawing the ire of doctors following the rules.

A dozen applicants are vying for a potentially lucrative license earmarked for a Black farmer who participated in decades-old litigation over discrimination in lending practices by the federal government.

A study led by Florida Gulf Coast University, Releaf App and CannaMD hopes to further clarify just what ratios of cannabinoids best reduce anxiety symptoms.